IMPACT OF OVERNIGHT DEXAMETHASONE SUPPRESSION ON THE ADRENAL ANDROGENRESPONSE TO AN ORAL GLUCOSE-TOLERANCE TEST IN WOMEN WITH AND WITHOUT POLYCYSTIC-OVARY-SYNDROME
Rp. Buyalos et al., IMPACT OF OVERNIGHT DEXAMETHASONE SUPPRESSION ON THE ADRENAL ANDROGENRESPONSE TO AN ORAL GLUCOSE-TOLERANCE TEST IN WOMEN WITH AND WITHOUT POLYCYSTIC-OVARY-SYNDROME, Human reproduction, 12(6), 1997, pp. 1138-1141
In order to test the hypothesis that adrenocortical over-activity, pos
sibly related to the stress of testing, may impact on the measurement
of circulating androgen concentrations during glucose-induced hyperins
ulinaemia, we prospectively screened 10 patients with the polycystic o
vary syndrome (PCOS) and nine healthy control women with an oral gluco
se tolerance test (OGTT), before and after the administration of dexam
ethasone, Blood sampling was performed at 0, 30, 60, 90, and 120 min f
ollowing the oral ingestion of 75 g of glucose, before and after the a
dministration of 1.0 mg dexamethasone on the evening prior to testing,
Total and free testosterone, androstenedione, dehydroepiandrosterone
(DHEA), DHEA sulphate (DHEAS), cortisol, glucose and insulin were asse
ssed during the 2 h OGTT. Women with PCOS had increased basal concentr
ations of free testosterone, total testosterone, androstenedione, and
insulin compared to control women, In women with PCOS an acute decline
in circulating concentrations of DHEAS occurred during the OGTT, In P
COS women there were no changes in other ovarian or adrenal androgens
during OGTT before or following dexamethasone administration, In contr
ol women DHEA concentrations declined during the OGTT, Following overn
ight dexamethasone suppression in control women, circulating concentra
tions of DHEAS and testosterone also declined, It is concluded that: (
i) in PCOS women only the concentration of circulating DHEAS decreased
during glucose-induced hyperinsulinaemia and dexamethasone administra
tion did not further alter androgen responses to an OGTT; (ii) it is p
ossible that, in these hyperandrogenic patients, the insulin-related s
uppression of adrenocortical testosterone and DHEA is negated by their
much greater ovarian secretion of these androgens; (iii) in control w
omen DHEA concentrations acutely declined during the OGTT and the admi
nistration of dexamethasone resulted in the acute decline of DHEA, DHE
AS, and testosterone; (iv) it appears that the stress related to testi
ng impacts on the androgen response to OGTT, at least in healthy women
.